Toboroz
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
NCT07476729· 3. fázis· Charite University, Berlin, Germany· Forrás
Toboroz
Revumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukemia (AML)
2025-521390-14-00· 2. fázis· Pediatric Research International GmbH· Forrás
Toboroz
Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
2025-520982-39-00· 3. fázis· Universita Degli Studi Di Milano Bicocca· Forrás
Toboroz
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05745714· 1/2. fázis· Princess Maxima Center for Pediatric Oncology· Forrás
Toboroz
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05751044· 1/2. fázis· Princess Maxima Center for Pediatric Oncology· Forrás
Toboroz
VyClo ITCC-092
2023-508050-26-00· 1. fázis· Prinses Maxima Centrum voor Kinderoncologie B.V.· Forrás
Toboroz
International open-label phase I dose escalation study of dinutuximab beta in combination with vincristine/doxorubicin/cyclophosphamide and ifosfamide/etoposide in pediatric, adolescent, and adult patients with GD2-positive Ewing sarcoma
2024-515245-42-00· 1. fázis· GPOH gGmbH· Forrás
Toboroz
Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
NCT06376162· 1. fázis· PedAL BCU, LLC· Forrás
Toboroz
Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
NCT06954311· Medical University Innsbruck· Forrás
Toboroz
Establishment of a Novel Flow Cytometric Diagnostic Assay to Effectively Evaluate Immune Reconstitution After Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia
NCT07899840· Fondazione Matilde Tettamanti Menotti De Marchi Onlus· Forrás
Toboroz
Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
NCT06485947· 1. fázis· Princess Maxima Center for Pediatric Oncology· Forrás
Toboroz
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
NCT07334301· 1/2. fázis· University of Birmingham· Forrás
Fut, nem toboroz
LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis
NCT02205762· 2/3. fázis· St. Anna Childrens Cancer Research Institute GmbH· Forrás
Toboroz
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
NCT05991388· 2/3. fázis· University of Birmingham· Forrás
Toboroz
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
NCT05658640· 1/2. fázis· Princess Maxima Center for Pediatric Oncology· Forrás
Toboroz
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
NCT05748171· 2. fázis· Pfizer· Forrás
Toboroz
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
NCT05327894· 3. fázis· Princess Maxima Center for Pediatric Oncology· Forrás
Fut, nem toboroz
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
NCT05183035· 3. fázis· PedAL BCU, LLC· Forrás
Toboroz
Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
NCT04925609· 1/2. fázis· Princess Maxima Center for Pediatric Oncology· Forrás
Toboroz
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
2022-501180-40-00· 3. fázis· GPOH gGmbH· Forrás
Toboroz
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years.
2024-510578-25-00· 3. fázis· The University Of Birmingham· Forrás
Toboroz
A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD
NCT04201210· 2. fázis· University of Regensburg· Forrás
Toboroz
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
NCT04625907· 1/2. fázis· University of Birmingham· Forrás
Toboroz
INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
NCT03838042· 1/2. fázis· University Hospital Heidelberg· Forrás
Toboroz
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
2022-501454-11-00· 3. fázis· GPOH gGmbH· Forrás
Toboroz
SIOP RANDOMET 2017
2023-508926-91-00· 3. fázis· GPOH gGmbH· Forrás
Toboroz
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035· 3. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás
Toboroz
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
NCT04043494· 3. fázis· University Hospital Muenster· Forrás
Fut, nem toboroz
Comparison of Carboplatin and Cisplatin in patients with extracranial malignant germ cell tumours
2023-507582-25-00· 3. fázis· Rheinische Friedrich-Wilhelms-Universitaet Bonn· Forrás
Toboroz
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
NCT03643276· 3. fázis· Martin Schrappe· Forrás
Toboroz
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
NCT03590171· 2. fázis· Charite University, Berlin, Germany· Forrás
Fut, nem toboroz
Paediatric Hepatic International Tumour Trial
NCT03017326· 3. fázis· University of Birmingham· Forrás
Fut, nem toboroz
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
NCT03007147· 3. fázis· Children's Oncology Group· Forrás
Fut, nem toboroz
Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
NCT03206671· 3. fázis· University Hospital Muenster· Forrás
Toboroz
Inotuzumab ozogamicin for Acute Lymphoblastic Leukemia
2023-504694-20-00· 1/2. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás
Toboroz
rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma
2024-516078-31-00· 2/3. fázis· The University Of Birmingham· Forrás
Toboroz
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
NCT01949129· 2/3. fázis· St. Anna Kinderkrebsforschung· Forrás